Ancrod proteins, their preparation and use

US6015685A · kind A · utility

Assignee

• BASF SE

Inventors

• Alfred Bach · Heidelberg, DE
• Karl-Hermann Strube · Speyer, DE
• Wolfgang Koerwer · Ludwigshafen, DE

Key dates

• Filing date: May 14, 1991
• Grant date: Jan 18, 2000
• Expiry date: May 14, 2011

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P15/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Pure glycosylated, partially glycosylated or unglycosylated polypeptides have the amino-acid sequence of ancrod, in which up to 5 amino acid residues can be replaced by residues of other natural amino acids, and are suitable for controlling diseases.